Literature DB >> 838199

HLA-types, C-peptide and insulin antibodies in juvenile diabetes.

J Ludvigsson, J Säfwenberg, L G Heding.   

Abstract

HLA-types were determined in 102 juvenile diabetics. HLA-B8 was found in 39 patients (RR 2.64; p less than 0.01) and HLA-BW15 in 32 patients (RR 1.33; n.s.). HLA-B7 was found in 14 patients (RR 0.40; p less than 0;05). There were no correlations between HLA-B8 or BW15 and family history of diabetes, occurrence of infection before onset of diabetes, ketonuria at onset or the age at onset of diabetes. Serum C-peptide, insulin binding capacity of IgG and total serum insulin, IRI, were determined in 94 patients who had had diabetes for more than two years and who were beyond the remission period. Measurable amounts of C-peptide were found in 33 patients (34.7%). There was no evidence of a relationship between any particular HLA-antigen and the B-cell function except for an increased incidence of do a decreased incidence of detectable C-peptide in patients with the combination HLA-B8, W15. Only four patients (4.3%) were lacking insulin antibodies; HLA-BW15 positive patients had higher levels of insulin antibodies than other groups, while HLA-B7 positive patients had lower levels; The results suggest that HLA-B7 and HLA-B18 might be associated with a different and perhaps milder form of juvenile diabetes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 838199     DOI: 10.1007/BF00996321

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  Letter: Is HLA-B7 a marker associated with a protective gene in juvenile-onset diabetes mellitus?

Authors:  H Ludwig; G Schernthaner; W R Mayr
Journal:  N Engl J Med       Date:  1976-05-06       Impact factor: 91.245

2.  HL-A8, W15 and T3 in juvenile onset diabetes mellitus.

Authors:  G Schernthaner; W R Mayr; M Pacher; H Ludwig; W Erd; M Eibl
Journal:  Horm Metab Res       Date:  1975-11       Impact factor: 2.936

3.  Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus.

Authors:  D P Singal; M A Blajchman
Journal:  Diabetes       Date:  1973-06       Impact factor: 9.461

4.  HL-A antigens and diabetes mellitus.

Authors:  J Nerup; P Platz; O O Andersen; M Christy; J Lyngsoe; J E Poulsen; L P Ryder; L S Nielsen; M Thomsen; A Svejgaard
Journal:  Lancet       Date:  1974-10-12       Impact factor: 79.321

5.  Radioimmunoelectrophoresis in the determination of insulin binding to IgG.

Authors:  A H Christiansen
Journal:  Horm Metab Res       Date:  1973-05       Impact factor: 2.936

6.  No relation between HL-A and juvenile diabetes.

Authors:  S Finkelstein; E Zeller; R L Walford
Journal:  Tissue Antigens       Date:  1972

7.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

8.  Letter: Juvenile diabetes and viruses.

Authors:  J Barbosa; H Noreen; F Goetz; R Simmons; J Najarian; E J Yunis
Journal:  Lancet       Date:  1976-02-14       Impact factor: 79.321

9.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

10.  C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control.

Authors:  J Ludvigsson; L G Heding; Y Larsson; E Leander
Journal:  Acta Paediatr Scand       Date:  1977-03
View more
  13 in total

1.  The histocompatibility system in juvenile, insulin-dependent diabetic multiplex kindreds.

Authors:  J Barbosa; R King; H Noreen; E J Yunis
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

2.  Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.

Authors:  S Madsbad
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

3.  Prevalence of residual B-cell function related to age at onset and genetic profile in newly diagnosed type I diabetics.

Authors:  C Giordano; A Galluzzo; F Pantò; C Caruso; G Bompiani
Journal:  Acta Diabetol Lat       Date:  1987 Oct-Dec

4.  HLA-typing in juvenile diabetics with and without positive family history and in families with one and two diabetic siblings.

Authors:  N Bengsch; J Köbberling; G Eckert; B Willms
Journal:  Diabetologia       Date:  1978-12       Impact factor: 10.122

5.  Evidence of an accelerated B-cell destruction in HLA-Dw3/Dw4 heterozygous children with type 1 (insulin-dependent) diabetes.

Authors:  M Knip; J Ilonen; A Mustonen; H K Akerblom
Journal:  Diabetologia       Date:  1986-06       Impact factor: 10.122

6.  BF types and the mode of inheritance of insulin-dependent diabetes mellitus (IDDM).

Authors:  D Raum; Z Awdeh; C A Alper
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

7.  Residual B cell function in diabetic children as determined by urinary C-peptide.

Authors:  J Aurbach-Klipper; R Sharph-Dor; L G Heding; M Karp; Z Laron
Journal:  Diabetologia       Date:  1983-02       Impact factor: 10.122

Review 8.  Type I diabetes mellitus.

Authors:  A G Cudworth
Journal:  Diabetologia       Date:  1978-05       Impact factor: 10.122

Review 9.  The modes of inheritance of insulin-dependent diabetes mellitus or the genetics of IDDM, no longer a nightmare but still a headache.

Authors:  J I Rotter
Journal:  Am J Hum Genet       Date:  1981-11       Impact factor: 11.025

10.  Residual beta cell function in insulin-dependent diabetes: evaluation by circadian determination of C-peptide immunoreactivity.

Authors:  B Canivet; M Harter; G Viot; N Balarac; B P Krebs
Journal:  J Endocrinol Invest       Date:  1980 Apr-Jun       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.